Karolinska Development AB (publ)
Karolinska Development AB (publ) (KDEVF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KDEVF · as of Jun 9, 2026
Key Statistics
Explore Karolinska Development AB (publ) Data
kdevf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
kdevf competitorsKDEVF
BSTG
EOFBY
ETXPF
HRPMF
KIARFStock Performance
Full HistoryAbout Karolinska Development AB (publ)
Karolinska Development AB (publ) operates as a venture capital firm, primarily focused on providing funding to nascent companies across seed, early, and growth stages. Its investment strategy targets …
what is karolinska development ab (publ) · kdevf stock overview · karolinska development ab (publ) company profile · who is karolinska development ab (publ) ceo · kdevf OTC · karolinska development ab (publ) headquarters · karolinska development ab (publ) business segments
About Stock Overview & Key Data
Karolinska Development AB (publ) (KDEVF) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 5, 2019. As of the latest trading session, KDEVF stock price is $0.26, with a market capitalization of $68.9M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2023, Karolinska Development AB (publ) reported revenue of $2.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Karolinska Development AB (publ) (KDEVF) stock price is $0.26. The stock is traded on OTC under the ticker symbol KDEVF. The 52-week range is $0.26 – $0.61.